Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617911 · ClinicalTrials.gov registry record · NA
Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy
A NA study, sponsored by Gaylord Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05617911: Clinical Trial NA study, sponsored by Gaylord Hospital.
NCT05617911 is a NA study that was terminated before completion, run by Gaylord Hospital. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05617911, a NA study, was terminated before completion, sponsored by Gaylord Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
Primary Outcome
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Interventions
- DEVICE Blood Flow Restriction Cuff
- PROCEDURE Sham and standard of Care Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-11-15 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Why NCT05617911 stopped before completion
NCT05617911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood Flow Restriction Cuff is the first listed.
NCT05617911 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05617911 about?
NCT05617911 is a clinical study titled "Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy". The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
What is the current status of trial NCT05617911?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-11-15. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT05617911?
The interventions under investigation include: Blood Flow Restriction Cuff (DEVICE), Sham and standard of Care Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05617911?
This trial is sponsored by Gaylord Hospital, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05617911's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI